Hematologist and Oncologist Eugene Frenkel Dies

Frenkel investigated drug resistance in cancers and how vitamin B12 deficiency damages neurons.

Written byAshley P. Taylor
| 2 min read
eugene frenkel ut southwestern medical center

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

HHematologist and oncologist Eugene Frenkel of the University of Texas Southwestern Medical Center died on June 21, 2019. He was 89. Frenkel’s research contributed to the understanding that vitamin B12 deficiency causes damage to neurons’ myelin sheath, resulting in neural dysfunction. Frenkel also studied drug resistance in breast and genitourinary cancers.

Three academic chairs at UT Southwestern and multiple cancer research funds have been established in Frenkel’s honor over the course of his career, according to a university statement.

Born in 1929 in Detroit, Michigan, Frenkel graduated from the University of Michigan Medical School in 1953. He interrupted his medical residency to serve as an officer and flight surgeon in the US Air Force. UT Southwestern recruited him to Dallas in 1962 as chief of the new Division of Hematology and Oncology. His 57-year career there ended with his death.

In the 1970s, working on animals and human tissue samples, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies